MishimaErika
Lv12
20 积分
2024-08-06 加入
-
Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma
5小时前
待确认
-
Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma
5小时前
已关闭
-
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study
1天前
已完结
-
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
1个月前
已完结
-
Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial
2个月前
已完结
-
Diagnosis and Treatment of Pulmonary Arterial Hypertension
2个月前
已完结
-
Diagnosis and Treatment of Pulmonary Arterial Hypertension
2个月前
已完结
-
Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in Children with Severe Aplastic Anemia: A Retrospective Study
2个月前
已完结
-
Molecular dynamics of targeting CD38 in multiple myeloma
2个月前
已完结
-
Direct in Vitro Comparison of Daratumumab with Surrogate Analogs of CD38 Antibodies MOR03087, SAR650984 and Ab79
3个月前
已完结